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Several reports have suggested the presence of anticipation in bipolar affective disorder
(BPAD). In addition, independent studies using the RED (repeat expansion detection) have
shown association between BPAD and longer CAG/CTG repeats. Therefore loci with large
CAG/CTG repeats are plausible candidates in the inheritance of BPAD. The present study
assesses the length of the repeats in four loci: the ERDA-1 locus which is known to account
for most of the long CAG repeats detected by RED, the SEF2-1b locus which is placed in a
region where positive linkage results have been reported and the loci MAB21L and KCNN3
as functional candidate genes. A Brazilian case-control sample with 115 unrelated BPAD
patients and 196 healthy control subjects and 14 multiply affected bipolar families was investi-
gated. With the case-control design the distribution of alleles between the two groups did
not approach statistical significance. The extended transmission disequilibrium test (ETDT)
performed in our families did not show evidence for linkage disequilibrium. Parametric and
non-parametric linkage analysis also did not provide support for linkage between any of the
four loci and BPAD. Our data do not support the hypothesis that variation at the polymorphic
CAG/CTG repeat loci ERDA-1, SEF2-1b, MAB21L or KCNN3 influence susceptibility to BPAD
in our sample. Molecular Psychiatry (2001) 6, 565–569.
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Introduction
Although a hereditary basis for bipolar disorder
(BPAD) has been consistently supported by genetic epi-
demiology studies,1 it has proved difficult to localise
predisposing genes. The attempts to identify suscepti-
bility genes may be summarised in two approaches:
either through the search for a genetic linkage of the
phenotype with genetic markers on the chromosomes
or through the demonstration of an association
between the disease phenotype and polymorphism in
candidate genes, chosen on the basis of a pathophysio-
logic hypothesis.
A new perspective arose in the early ’90s with the
discovery of the ‘dynamic mutation’, a novel class of
genetic mutation related with trinucleotide repeats
expansion (TRE). A growing number of diseases has
been found resulting from the expansion of reiterated
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sequences of trinucleotides such as Huntington’s dis-
ease, myotonic dystrophy, fragile X syndrome, Fried-
reich’s ataxia and spinocerebellar ataxias. Almost all of
the TRE disorders affect the central nervous system,
display variable phenotypic expressions and increase
the disease severity or decrease the age of onset
throughout successive generations of a family, a
phenomenon that is termed anticipation.2,3
A large number of reports has suggested the presence
of anticipation in BPAD,4–7 although these data should
be interpreted with caution due to some ascertainment
biases that can not be ruled out (such as recall bias,
cohort effect, decreased fertility, sensitisation to
illness).8 In addition, many aspects of inheritance of
bipolar disorder could be explained by TRE (such as
variable phenotypic expression, skipped generations or
twin discordance).9
The RED (repeat expansion detection), a strategy
developed to detect repeat expansions on genomic
DNA without prior knowledge of its location,10 has
shown association between BPAD and longer trinucle-
otide CAG/CTG repeats,11–15 although not all studies
found a significant association.16–18
In the light of these data it has been postulated that
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loci with CAG/CTG repeat expansions could be candi-
date genes for the genetic inheritance of bipolar dis-
order. The present study investigated four CAG/CTG
loci using a Brazilian case-control sample and BPAD
multiply affected families. The four loci were:
The ERDA1 (MIM 603279) also called Dir-I, a repeat
localised on 17q21.3, highly polymorphic (10–92
repeats) and whose flanking sequences showed no
homology with any reported gene,19 although Northern
blot analyses indicate that it is expressed in the brain
and other tissues.20 This repeat is known to account for
most of the long CAG repeats detected by RED.21,22
The highly polymorphic CAG/CTG repeat (typically
10–37 repeats) which is placed within the third intron
of transcription factor gene SEF2-1b (MIM 602272).
This locus maps to chromosome 18q21.1,23 a region
where positive linkage results have been reported for
BPAD families.24,25
The polymorphic CAG/CTG repeat locus (6–31
copies) identified within the 5 untranslated region of
the gene MAB21L (MIM 601280). This gene is localised
on 13q13 and encodes a protein regulator of neuronal
development.26
The fourth, a polymorphic repeat coding for a poly-
glutamine stretch in the exon 1 of the KCNN3 (MIM
602983) formerly named hSKCa3.27 This CAG repeat
localised on 1q21 is an exception from the previous
ones, because it showed no sufficiently large alleles to
explain the findings of RED studies in BPAD-affected
patients and no allelic instability has been reported
during parental transmission.3 Since this gene encodes
a calcium gated potassium channel, these CAG repeat
arrays are of interest because of the function of gene in
which they reside.2
Materials and methods
Subjects
Families Fourteen probands had families available
for a linkage analysis. DNA was obtained from 96 mem-
bers of these families who were interviewed personally
by a psychiatrist using the Schedule for Affective Dis-
order and Schizophrenia—lifetime version (SADS-L).
Forty-two individuals fulfilled the DSM-III-R criteria
for BPAD, 16 had spectrum disorders (major
depression, schizoaffective), and 38 were currently
unaffected. Individuals with spectrum disorders were
considered affected in linkage analysis.
BPAD patients A hundred and fifteen unrelated
patients with BPAD (62% females), aged between 18–
80 years (mean age 43, SD ± 12) were recruited from
public psychiatric assistance services in the Sa˜o Paulo
City metropolitan area. All patients fulfilled the DSM-
III-R criteria for BPAD after psychiatric interviews and
analysis of medical notes. Venous blood samples were
collected after written informed consent was obtained.
Controls A hundred and ninety-six ethnically
matched healthy control subjects (50% females) aged
between 18–60 years (mean age 33, SD ± 9) were selec-
ted from unrelated subjects admitted to the Blood
Donation Center of the Fundac¸a˜o Pro´-Sangue/Sa˜o
Paulo University Medical School. An attempt to match
both groups according to ethnic origin was based on
the phenotype (pigmentation of the abdomen, hair col-
our and type and conformation of the nose and lips)
and family history assessed by two different phys-
icians.28 The ethnic distribution of both groups was as
follows: 45% Caucasian, 45% mulatto and 10% black.
Venous blood was obtained for genomic DNA extrac-
tion after consent had been given.
Genotyping
The polymorphic CAG/CTG repeats of the studied loci
were amplified by PCR using the following primer
pairs, previously described:20,23,26,27 for ERDA1
f:(5ACCAATAAGACTATCAATGGC3), b:(5TTATAA
CCCTGTCCAGTCAGTG3); for SEF21b f:(5AATCCA
AACCGCCTTCCAAGT3), b:(5CCAAAACTTCCGAAA
GCCATTTCT3); for MAB21L f:(5GATAAAAGGAAG
GGAAAA3), b:(5CAGAAATGGATCAAAAAT3) and
for KCNN3 f:(5AAGTGCCCCTGTCCATCCTCT3),
b:(5GCCAAGCAAGTGGTCATTGAG3). Amplification
conditions for thermal cycling (PTC-200, MJ Research,
Watertown, MA, USA) of ERDA1 and SEF2–1b con-
sisted of an initial denaturation at 95°C for 5 min, fol-
lowed by 30 cycles at 95°C for 50 s, annealing at 56°C
for 100 s, extension at 72°C for 60 s and finally an
elongation step at 72°C for 6 min. For MAB21L we used
an initial denaturation at 96°C for 2 min, followed by
35 cycles of 96°C for 30 s, 52°C for 30 s, 72°C for 60 s
and final extension at 72°C for 7 min. For KCNN3 a 5
primary denaturation at 95°C was followed by 30
cycles of 96°C for 45 s, 59°C for 45 s, 72°C for 45 s and
finally an extension at 72°C for 7 min.
PCR was performed in a total volume of 25 l con-
taining 40–100 ng of genomic DNA, 12.5 pM of each
primer, buffer with 50 mM KCl, 2 mM MgCl2, 10 mM
Tris, 125 M of each dNTP, 0.1% Triton, 1.25 l of the
DMSO 5% and 0.5 U of Taq Polymerase.
The PCR products were electrophoresed on denatur-
ing 7% polyacrylamide gels and visualised after stain-
ing with SYBR Gold (Molecular Probes, Eugene, OR,
USA) in direct fluorescence apparatus (Storm System,
Molecular Dynamics, Sunnyvale, CA, USA). Initially,
the size of the bands was determined by comparison
to a known sequence ladder and the number of repeats
was estimated based on the allele lengths. Later, the
alleles of modal frequency of each loci were sequenced
on an ABI 377 DNA sequencer (Applied Biosystems,
Foster City, CA, USA).
Because expanded alleles could be resistant to PCR
amplification, all apparent homozygous and PCR
‘dropouts’ of loci ERDA1 and SEF2-1b (‘super’ alleles
have been reported in both) were reamplified with PCR
conditions optimised to amplify large DNA fragments.
These conditions consisted of mixed reactions contain-
ing the same components described above, but with the
use of 1 U of eLONGase enzyme (Gibco-BRL, Rockville,
MD, USA) instead of Taq DNA polymerase. In addition,
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Figure 1 Allele frequency at each locus in BPAD patients and control subjects.
a program for touchdown PCR was performed as fol-
low: initial denaturation at 94°C for 5 min; 15 cycles
of 91°C for 50 s, 57°C for 100 s, 72°C for 60 s; 20 cycles
of 94°C for 50 s, 56°C for 100 s, 72°C for 60 s and a
final extension at 72°C for 9 min.
Statistical analysis
The distribution of alleles at each locus was compared
in the patients and controls using the Mann–Whitney
U test (two-tailed) implemented in the statistical pack-
age SPSS for windows version 7.0. We also used the
CLUMP program, which is useful to test association
between disease and alleles at highly polymorphic
loci.29 This program obtains empirical P-values by a
permutation test procedure.
The test for non-random transmission of alleles on
affected individuals from our 14 families was perfor-
med using the Extended Transmission Disequilibrium
Test (ETDT)30 and linkage analysis was performed
using the computer program GENEHUNTER version
1.3.
Results
The alleles obtained in the ERDA1 locus showed a
repeat number of 10–90 copies with heterozygosity of
83% for BPAD patients and 80% for controls. In the
SEF2-1b locus alleles estimated at 11–60 repeats were
found with heterozygosity of 82% for BPAD and 84%
for controls. The MAB21L displayed alleles of 10–28
repeats with heterozygosity indices for BPAD at 91%
and for controls at 89%. Finally, the KCNN3 showed
alleles of 16–22 repeats with heterozygosity of 63% on
the BPAD and 68% on the controls.
The distribution of the allele frequency at each locus
in 115 patients and 196 controls is represented in Fig-
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ure 1. The alleles with rare frequency were grouped
together with the closest adjacent alleles.
No significant differences were observed in the allele
distribution between BPAD patients and control sub-
jects by Mann–Whitney U test at either the ERDA1
locus (U = 42299.5, W = 119327.5, z = −1.320, P =
0.187), SEF2–1b (U = 43659.5, W = 70224.5, z = −0.673,
P = 0.501), MAB21L (U = 43967.5, W = 120995.5, z =
−0.526, P = 0.599) or KCNN3 (U = 43408.5, W =
120436.5, z = −0.878, P = 0.380). The comparison of the
allelic frequency between the groups using the CLUMP
program also did not demonstrate significant differ-
ences (ERDA1 2 = 4.81, 7 df, P = 0.68; SEF2–1B 2 =
4.05, 7 df, P = 0.78; MAB21L 2 = 6.18, 6 df, P = 0.40;
KCNN3 2 = 0.94, 3 df, P = 0.81)
The family study using the ETDT did not show pref-
erence for transmission of any allele or genotype in
each locus to affected members, ie the number of trans-
mitted alleles to affected individuals was not different
from the number of nontransmitted alleles. The results
were: ERDA1 allele-wise 2 = 11.1, 7 df, P = 0.14; geno-
type-wise 2 = 17.4, 14 df, P = 0.23; SEF2-1b allele-wise
2 = 11.6, 10 df, P = 0.32; genotype-wise 2 = 4.4, 6 df,
P = 0.62; MAB21L allele-wise 2 = 5.8, 6 df, P = 0.45;
genotype-wise 2 = 12.6, 11 df, P = 0.32 and KCNN3
allele-wise 2 = 0.9, 4 df, P = 0.93; genotype-wise 2 =
0.9, 4 df, P = 0.93.
The highest Lod score obtained in a parametric link-
age analysis was −2.014 at KCNN3 locus under a domi-
nant model, indicating nonlinkage of the studied loci
with BPAD. Nonparametric linkage analysis also
showed no statistical significance for sharing alleles
identical by descent for ERDA1 (P = 0.27), SEF2-1b (P
= 0.6), MAB21L (P = 0.83), and KCNN3 (P = 0.59).
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Discussion
Early investigations with these repeats displayed inter-
esting findings: at least two studies reported that 90%
of larger CAG repeats detected by RED could be
explained by expansions on the loci ERDA-1 and SEF2-
1B.21,22 In the ERDA-1 locus, Vincent et al documented
the inheritance of a very large allele which expanded
the number of repeats (±115 repeats) through the trans-
mission in a family with childhood onset depression31
and Verheyen et al found a modest association (P =
0.032) between larger alleles (40 repeats) in this locus
and BPAD.32 Lindblad et al reported that the larger
alleles of SEF2-1b (40 repeats) are over-represented
in patients with familial affective disorder (P  0.04),
conferring an odds ratio of a 2.6–2.8 fold higher risk
factor for this disorder.22 A large CAG repeat at the
MAB21L locus (46 repeats) was identified in a subject
with a bipolar disorder type II phenotype.26 Finally,
Chandy et al have shown a trend for association
between larger repeats of CAG in the KCNN3 locus
(20 repeats) and BPAD.27
The results of our study, however, did not reveal dif-
ferences in the distribution of the alleles between 115
Brazilian unrelated BPAD patients and the 196 healthy
controls. Furthermore, it did not demonstrate cosegre-
gation of larger alleles with the affected phenotype in
the members of the 14 pedigrees.
As in other similar studies, the statistical power is
an important issue in the interpretation of the findings.
Power statistical analysis performed on EpiInfo
software v. 6.0 showed that, assuming a frequency of
0.05 for the larger alleles, our sample had approxi-
mately 83–89% power to detect larger alleles as a sus-
ceptibility factor associated with an odds ratio of 2.6–
2.8. as related by Lindblad et al.22
The mean age of the control sample is lower than the
bipolar group, and it is possible that some individuals
from the control group may eventually develop BPDA
when they get older. However, since the population
prevalence of BPAD is low (1%), the potential bias
added by this difference is very small. In addition, our
results were similar in both population and family-
based approaches.
One methodological issue regarding the PCR analysis
of these loci might be that preferential amplification of
small repeats leads to a failure of larger alleles to be
amplified and therefore to the misclassification of the
heterozygous by not showing one very large repeat as
homozygous. We tried to avoid this apparent error,
reamplifying the homozygous individuals with PCR
conditions optimised for larger alleles, although we
can not be sure that the optimisation was sufficient to
identify this issue. However, the heterozygosity indices
were determined for each loci studied in both groups
and no differences were observed. Thus, it is unlikely
that missing alleles influenced the final result.
In conclusion, the data obtained in this investigation
did not support the hypothesis that larger CAG/CTG
repeats at the loci ERDA-1, SEF2-1B, MAB21L and
KCNN3 play a role in the susceptibility for BPAD in
our Brazilian patients. Some authors suggested that the
total number of potential candidate genes for bipolar
disorder could reach as much as 20 000.33 However, if
the research is focused only on CAG/CTG repeats, the
total number of loci can be restricted to approximately
1500,34 making the investigation easier to approach.
We explored only a very small fraction of these types
of loci. Thus, it is important to stress that our results
do not reject the hypothesis that CAG/CTG repeats par-
ticipate in the genesis of bipolar disorder. Therefore,
we consider that the investigation of loci with
CAG/CTG repeats continues to be an attractive strategy.
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